BSE filing, BSE: 539378. Summary written from the filing by ALFA Finder's alert engine.
More from Soni Medicare Ltd
All →Soni Medicare Annual Report
Soni Medicare Limited has submitted its Annual Report and notice for the 38th Annual General Meeting for the financial year 2025-26.
Soni Medicare Annual General Meeting
Soni Medicare Limited has scheduled its 38th Annual General Meeting for September 29, 2026. The company also announced book closure dates for this event.
Soni Medicare Board Meeting Outcome
Soni Medicare announced the outcome of its board meeting, approving the annual report, convening the 38th AGM, and updating director designations and corporate loan limits.
Soni Medicare Management Change
Soni Medicare Ltd has appointed Mr. Namit Soni as an Additional Executive Director, effective August 14, 2026.
Soni Medicare Q1 FY27 Results: Net Loss of ₹1.2 Cr, Loss Widens
Soni Medicare Ltd reported revenue from operations of ₹4.6 Cr (-37.0% YoY) and a net loss of ₹1.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹1.2 Cr
Soni Medicare Board Meeting Date
Soni Medicare Ltd has scheduled a board meeting for August 14, 2026. The board will consider and approve unaudited financial results for the June 2026 quarter.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.